Aerie Pharmaceuticals Inc
AERIDelisted Nov 21, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001337553
Aerie Pharmaceuticals Inc was delisted on Nov 21, 2022; its insiders filed their last Form 4 on Nov 21, 2022; 156 institutions reported holding it in 13F filings for Q3 2022, worth $710.6M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Aerie Pharmaceuticals Inc changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 156 | 3 | 0 | −153 |
| Shares | 47.0M | 2.40M | 0 | −44.6M (−100.0%) |
| Value | $710.6M | $36.3M | $0 | −$674.3M (−100.0%) |
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (0)
Institutions that held Aerie Pharmaceuticals Inc at the end of Q4 2022 but not at the end of Q3 2022.
None.
Sold out (153)
Institutions that held Aerie Pharmaceuticals Inc at the end of Q3 2022 and filed for Q4 2022 without it.
Showing the largest 100 of 153 by value.
Not filed for Q4 2022 yet (3)
Institutions that held Aerie Pharmaceuticals Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Jefferies Group LLC | 2,361,000 | $35.7M |
| S. Muoio & Co. LLC | 36,655 | $555.0K |
| Siena Capital LLC | 8 | $0 |